Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretation
出版年份 2017 全文链接
标题
Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretation
作者
关键词
Antimicrobial resistance, HIV-1, Sequence analysis, HIV, Nucleosides, Protease inhibitor therapy, Protease inhibitors, Reporter gene assay
出版物
PLoS One
Volume 12, Issue 7, Pages e0181357
出版商
Public Library of Science (PLoS)
发表日期
2017-07-29
DOI
10.1371/journal.pone.0181357
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Commonly Transmitted HIV-1 Drug Resistance Mutations in Reverse-Transcriptase and Protease in Antiretroviral Treatment–Naive Patients and Response to Regimens Containing Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide
- (2017) Nicolas A. Margot et al. JOURNAL OF INFECTIOUS DISEASES
- Lack of impact of pre-existing T97A HIV-1 integrase mutation on integrase strand transfer inhibitor resistance and treatment outcome
- (2017) Michael E. Abram et al. PLoS One
- Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration
- (2017) Soo-Yon Rhee et al. EBioMedicine
- High resistance barrier to tenofovir alafenamide is driven by higher loading of tenofovir diphosphate into target cells compared to tenofovir disoproxil fumarate
- (2016) Nicolas A. Margot et al. ANTIVIRAL RESEARCH
- Characterization of HIV-1 Resistance to Tenofovir AlafenamideIn Vitro
- (2015) Nicolas A. Margot et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dolutegravir Resistance Mutation R263K Cannot Coexist in Combination with Many Classical Integrase Inhibitor Resistance Substitutions
- (2015) Kaitlin Anstett et al. JOURNAL OF VIROLOGY
- Differential Effects of the G118R, H51Y, and E138K Resistance Substitutions in Different Subtypes of HIV Integrase
- (2015) Peter K. Quashie et al. JOURNAL OF VIROLOGY
- G118R and F121Y mutations identified in patients failing raltegravir treatment confer dolutegravir resistance
- (2014) Soundasse Munir et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- New raltegravir resistance pathways induce broad cross-resistance to all currently used integrase inhibitors
- (2014) I. Malet et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adults
- (2013) Nicola E. Mackie et al. AIDS
- Biochemical Analysis of the Role of G118R-Linked Dolutegravir Drug Resistance Substitutions in HIV-1 Integrase
- (2013) Peter K. Quashie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study
- (2013) Pedro Cahn et al. LANCET
- Clinical Evaluation of Rega 8: An Updated Genotypic Interpretation System That Significantly Predicts HIV-Therapy Response
- (2013) Jurgen Vercauteren et al. PLoS One
- Viral fitness cost prevents HIV-1 from evading dolutegravir drug pressure
- (2013) Thibault Mesplède et al. Retrovirology
- Standardized Comparison of the Relative Impacts of HIV-1 Reverse Transcriptase (RT) Mutations on Nucleoside RT Inhibitor Susceptibility
- (2012) George L. Melikian et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Predicting Response to Antiretroviral Treatment by Machine Learning: The EuResist Project
- (2012) Maurizio Zazzi et al. INTERVIROLOGY
- The HIVdb System for HIV-1 Genotypic Resistance Interpretation
- (2012) Michele W. Tang et al. INTERVIROLOGY
- The Activity of the Integrase Inhibitor Dolutegravir Against HIV-1 Variants Isolated From Raltegravir-Treated Adults
- (2012) Mark R. Underwood et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study
- (2012) Joseph J. Eron et al. JOURNAL OF INFECTIOUS DISEASES
- Substitutions at Amino Acid Positions 143, 148, and 155 of HIV-1 Integrase Define Distinct Genetic Barriers to Raltegravir Resistance In Vivo
- (2012) S. Fransen et al. JOURNAL OF VIROLOGY
- The development of an expert system to predict virological response to HIV therapy as part of an online treatment support tool
- (2011) Andrew D. Revell et al. AIDS
- Short Communication Prevalence of Susceptibility to Etravirine by Genotype and Phenotype in Samples Received for Routine HIV Type 1 Resistance Testing in the United States
- (2011) Gaston Picchio et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Genotypic and Phenotypic Characterization of HIV-1 Isolates Obtained From Patients on Rilpivirine Therapy Experiencing Virologic Failure in the Phase 3 ECHO and THRIVE Studies
- (2011) Laurence Rimsky et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Cross-resistance Profile of the Novel Integrase Inhibitor Dolutegravir (S/GSK1349572) Using Clonal Viral Variants Selected in Patients Failing Raltegravir
- (2011) Filippo Canducci et al. JOURNAL OF INFECTIOUS DISEASES
- Characterization of the R263K Mutation in HIV-1 Integrase That Confers Low-Level Resistance to the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir
- (2011) P. K. Quashie et al. JOURNAL OF VIROLOGY
- Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study
- (2011) Jean-Michel Molina et al. LANCET INFECTIOUS DISEASES
- Resistance profile of etravirine: combined analysis of baseline genotypic and phenotypic data from the randomized, controlled Phase III clinical studies
- (2010) Johan Vingerhoets et al. AIDS
- HIV-1 Protease Mutations and Protease Inhibitor Cross-Resistance
- (2010) S.-Y. Rhee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroAntiretroviral Properties of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor
- (2010) Masanori Kobayashi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of HIV-1 Genotypic Resistance Test Interpretation Systems in Predicting Virological Outcomes Over Time
- (2010) Dineke Frentz et al. PLoS One
- Predicting the Response to Combination Antiretroviral Therapy: Retrospective Validation of geno2pheno‐THEO on a Large Clinical Database
- (2009) André Altmann et al. JOURNAL OF INFECTIOUS DISEASES
- Predictive Value of HIV‐1 Genotypic Resistance Test Interpretation Algorithms
- (2009) Soo‐Yon Rhee et al. JOURNAL OF INFECTIOUS DISEASES
- Abacavir–Lamivudine versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy
- (2009) Paul E. Sax et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resistance Profile of Darunavir: Combined 24-Week Results from the POWER Trials
- (2008) Sandra de Meyer et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Mutations Associated with Failure of Raltegravir Treatment Affect Integrase Sensitivity to the Inhibitor In Vitro
- (2008) I. Malet et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Determination of Clinically Relevant Cutoffs for HIV-1 Phenotypic Resistance Estimates Through a Combined Analysis of Clinical Trial and Cohort Data
- (2008) Bart Winters et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- A study of seven rule-based algorithms for the interpretation of HIV-1 genotypic resistance data in Thailand
- (2008) Vongsakorn Poonpiriya et al. JOURNAL OF VIROLOGICAL METHODS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started